Faslodex
In the US, patients with advanced HR-positive breast cancer are given priority review for the combination of capivasertib and Faslodex
SG Tylor
Source- Astrazeneca The US Food and Drug Administration (FDA) has accepted and granted Priority Review to AstraZeneca’s New Drug Application ...
